• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, July 22, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

ZEISS CT LUCIA – Australian surgeons give early feedback on new IOL

by Myles Hume
November 29, 2022
in Devices, Local, News, Products
Reading Time: 4 mins read
A A
Melbourne ophthalmologist Dr Anton van Heerden performing cataract surgery.

Melbourne ophthalmologist Dr Anton van Heerden performing cataract surgery.

Share on FacebookShare on Twitter

Australian cataract surgeons with early access to the ZEISS CT LUCIA 621 IOL have reported favourably on the company’s latest monofocal technology, particularly in terms of the lens design, patient outcomes and surgical experience.

Despite an increase in IOL offerings in recent years, the company says monofocal IOLs remain the most regularly implanted design in Australia New Zealand. With IOL innovations often focused on multifocal solutions, innovation in the monofocal space has lagged behind.

Despite this, ZEISS has launched the CT LUCIA 621 monfocal IOL. For many, RANZCO Brisbane 2022 was the first opportunity to experience the new ZEISS implant – and initial feedback was positive.

Post-conference, a small group of surgeons were the first to implant CT LUCIA 621 in Australia and asked to report their initial thoughts.

This included Dr Anton van Heerden, a cataract and refractive surgeon, and director and lead ophthalmologist in his private practices in Melbourne.

“I have had the privilege of having early access to the new ZEISS CT LUCIA 621 monofocal IOL. This new IOL gives precision ZEISS optics in a new C-loop hydrophobic platform,” he said.

Dr van Heerden highlighted the benefits of the ZEISS Optic (ZO) Asphericity Concept, something the company developed to compensate for a wide range of aberrations resulting from different corneal shapes and lens positions

“The platform has a unique forgiving aspheric design which gives great outcomes independent of IOL centration and pupil size,” he added.

Dr Georgia Cleary.

Corneal, cataract and refractive surgeon Dr Georgia Cleary, who is head of department within the Surgical Ophthalmology Services at The Royal Victoria Eye & Ear Hospital and consultant at Bayside Eye Specialists, identified clear benefits in the handling properties of the fully pre-loaded implant.

“My initial experience with the Zeiss CT LUCIA 621 hydrophobic IOL has been overwhelmingly positive. The CT LUCIA 621 is fully pre-loaded. A simple addition of OVD (viscoelastic) directly into the cartridge is all that is required, before it is closed, ready for a single-handed implantation,” she said.

It was also apparent that the design of the optic-haptic junction had further enhanced the handling properties and user experience with this implant, she said.

“Implantation into the capsular bag was smooth and comfortable, and the IOL optic could be safely moved within the capsular bag during irrigation and aspiration (I/A). Once I/A was complete, no further manipulation was required to centre the IOL.”

The most important consideration for both surgeons was how this lens performed clinically in these early cases. Dr van Heerden and Dr Cleary agreed when it came to patient outcomes.

“I reviewed my first case day 15 post-operatively, and was delighted that the patient had 6/5 uncorrected visual acuity, with no refractive error. The optic material was beautifully clear on slit lamp examination. I look forward to growing my experience with the CT LUCIA 621 IOL,” Dr Cleary stated.

Dr van Heerden added: “My experience thus far has seen exceptional visual outcomes. I look forward to further expansion of IOL options in this new IOL design.” 

CT LUCIA 621 early user bios

Dr Anton Van Heerden is a cataract and refractive surgeon, retina sub-specialist and comprehensive general ophthalmologist. He is the former head of unit of Surgical Ophthalmology Services at The Royal Victorian Eye and Ear Hospital.  He is a director of Armadale Eye Clinic, Mornington Peninsula Eye Clinic and is the principal surgeon at Eye Laser Specialists.

Dr Georgia Cleary is a corneal, cataract and refractive surgeon. She is head of department for Surgical Ophthalmology Services at The Royal Victoria Eye & Ear Hospital and consultant at Bayside Eye Specialists. Dr Cleary holds a PhD with a research interest in cataract surgery and IOLs.

More information on ZEISS CT LUCIA IOLs can be accessed here.

More reading

Corporate responsibility: Upholding the common good

ZEISS launches ClearView Finished Single Vision lenses

First glimpse of ZEISS innovations at Australian Experience Showcase events

Related Posts

The spring daylight saving transition when clocks move forward by one hour, was associated with a 20–30% higher risk of developing some vision-threatening retinal vascular diseases. Image: Vladimir/stock.adobe.com.

Daylight saving linked to retinal disease risk, US study finds

by Helen Carter
July 22, 2026

The switch to daylight saving may increase the risk of developing serious retinal disease, according to a large US study....

ZEISS MCI Patents

Webinar to focus on use of OCT in clinical optometry

by Rob Mitchell
July 22, 2026

ZEISS is inviting eyecare professionals to join an online, hosted webinar session highlighting OCT in Clinical Optometry. CPD will be available...

Rodenstock Australia GM Tim McCann (from left), See Side Optical co-owners Linda Simpson and Sonya Broadhead, and ODA CEO April Petrusma. Image: ODA.

ODA profile: Being you is your superpower

by Sonya Broadhead
July 21, 2026

MEMBER PROFILE Name: Sonya Broadhead Position: Director/optical dispenser/co-owner Location: See Side Optical, Thirroul, NSW Years in industry: More than 28...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited